BML Investment Partners Increases Stake in Outset Medical to 13.6%

BML Investment Partners, L.P. filed an amended Schedule 13G on May 18, 2026, disclosing an increased stake in Outset Medical, Inc. (OM). As of the event date on May 15, 2026, the filer reported beneficial ownership of 2,519,701 shares of common stock, representing 13.6% of the company. This is an increase from their previous reported position of 2,196,701 shares, or 11.8% of the company. The shares are held with shared voting and dispositive power. BML Capital Management, LLC serves as the general partner, and Braden M. Leonard is the managing member, thereby being deemed an indirect owner of the shares. The filing was made under Rule 13d-1(c), indicating a passive investment intent. The reporting persons disclaim that they constitute a statutory group. The filing reflects an additional acquisition of 323,000 shares since the prior disclosure, further solidifying BML Investment Partners' position as a significant shareholder in the San Jose-based medical technology company.